Lenny Van Bon

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Haemostatic changes and bleeding with anti-IL-6 directed therapy in autoimmune diseases.

Haemostatic changes and bleeding with anti-IL-6 directed therapy in autoimmune diseases.

Journal: British journal of pharmacology

Published: January 26, 2026

Glucocorticoid tapering strategies in polymyalgia rheumatica: a systematic literature review.

Glucocorticoid tapering strategies in polymyalgia rheumatica: a systematic literature review.

Journal: Rheumatology (Oxford, England)

Published: October 03, 2025

Recurrent vertebrobasilar stroke in giant cell arteritis associated with progressive prostate carcinoma: a case report and literature review.

Recurrent vertebrobasilar stroke in giant cell arteritis associated with progressive prostate carcinoma: a case report and literature review.

Journal: Clinical rheumatology

Published: September 17, 2025

Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion.

Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion.

Journal: Rheumatology advances in practice

Published: November 18, 2024

An in-depth comparison of vascular inflammation on ultrasound, FDG-PET/CT and MRI in patients with suspected giant cell arteritis.

An in-depth comparison of vascular inflammation on ultrasound, FDG-PET/CT and MRI in patients with suspected giant cell arteritis.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 26, 2024

Investigating interferon type I responses in patients with suspected giant cell arteritis and polymyalgia rheumatica.

Investigating interferon type I responses in patients with suspected giant cell arteritis and polymyalgia rheumatica.

Journal: Clinical and experimental immunology

Published: June 05, 2024

Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients.

Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients.

Journal: Frontiers in immunology

Published: March 30, 2023

External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic.

External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic.

Journal: RMD open

Published: February 23, 2023

Comment on: Validation of the Southend giant cell arteritis probability score in a Scottish single-centre fast-track pathway.

Comment on: Validation of the Southend giant cell arteritis probability score in a Scottish single-centre fast-track pathway.

Journal: Rheumatology advances in practice

Published: March 22, 2022

Rituximab dose-dependent infection risk in rheumatoid arthritis is not mediated through circulating immunoglobulins, neutrophils or B cells.

Rituximab dose-dependent infection risk in rheumatoid arthritis is not mediated through circulating immunoglobulins, neutrophils or B cells.

Journal: Rheumatology (Oxford, England)

Published: December 16, 2021

Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis.

Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis.

Journal: Journal of clinical medicine

Published: December 09, 2020

Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.

Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 09, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026